Personal information

Websites & social links

Web of science (Publons)
ReserchGate

Activities

Collapse all

Employment (2)

Instituto Politécnico Nacional Escuela Superior de Medicina: Mexico City, MX

2020-09-21 to present | Professor (Bioquímica médica I)
Employment
Source: Self-asserted source
Samuel Álvarez-Almazán

Universidad Nacional Autónoma de México Facultad de Estudios Superiores Cuautitlán: Cuautitlan Izcalli, Estado de México, MX

2015 to present | Professor/Researcher (Ciencias biológicas)
Employment
Source: Self-asserted source
Samuel Álvarez-Almazán

Education and qualifications (1)

Instituto Politécnico Nacional Escuela Superior de Medicina: Mexico City, MX

2016 to 2020 | Doctor of Philosophy (Medicine (Biochemistry))
Education
Source: Self-asserted source
Samuel Álvarez-Almazán

Professional activities (1)

Consejo Nacional de Ciencia y Tecnología: Mexico City, MX

2021 | National Researcher candidate level
Distinction
Source: Self-asserted source
Samuel Álvarez-Almazán

Works (10)

Effect of Different Karyophilic Peptides on Physical Characteristics and In Vitro Transfection Efficiency of Chitosan-Plasmid Nanoparticles as Nonviral Gene Delivery Systems

Molecular Biotechnology
2024-02-24 | Journal article | Supervision
DOI: 10.1007/s12033-024-01087-9
Part of ISSN: 1073-6085
Part of ISSN: 1559-0305
Contributors: María E. Aranda-Barradas; Héctor Eduardo Coronado-Contreras; Yareli Lizbeth Aguilar-Castañeda; Karen Donají Olivo-Escalante; Francisco Rodolfo González-Díaz; Carlos Gerardo García-Tovar; Samuel Álvarez-Almazán; Susana Patricia Miranda-Castro; Alicia Del Real-López; Abraham Méndez-Albores et al.
Source: Self-asserted source
Samuel Álvarez-Almazán

Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies

International Journal of Molecular Sciences
2023-08-15 | Journal article
DOI: 10.3390/ijms241612812
Contributors: Samuel Álvarez-Almazán; Luz Cassandra Solís-Domínguez; Paulina Duperou-Luna; Teresa Fuerte-Gómez; Martin González-Andrade; María E. Aranda-Barradas; Juan Francisco Palacios-Espinosa; Jaime Pérez-Villanueva; Félix Matadamas-Martínez; Susana Patricia Miranda-Castro et al.
Source: check_circle
Crossref

Impact of Molecular Symmetry/Asymmetry on Insulin-Sensitizing Treatments for Type 2 Diabetes

Symmetry
2022-06 | Journal article | Author
DOI: 10.3390/sym14061240
Contributors: Jessica Georgina Filisola-Villaseñor; María E. Aranda-Barradas; Susana Patricia Miranda-Castro; Jessica Elena Mendieta Wejebe; Amaranta Sarai Valdez Guerrero; Selene Amasis Guillen Castro; Macario Martínez Castillo; Feliciano Tamay-Cach; Samuel Álvarez-Almazán
Source: check_circle
Multidisciplinary Digital Publishing Institute

Effect of molecular weight of chitosan on the physicochemical, morphological, and biological properties of polyplex nanoparticles intended for gene delivery

Carbohydrate Polymer Technologies and Applications
2022-06-14 | Journal article
DOI: 10.1016/j.carpta.2022.100228
Part of ISSN: 2666-8939
Source: Self-asserted source
Samuel Álvarez-Almazán

In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents

PPAR Research
2021-12-31 | Journal article
DOI: 10.1155/2021/5100531
Part of ISSN: 1687-4765
Part of ISSN: 1687-4757
Source: Self-asserted source
Samuel Álvarez-Almazán

A New Symmetrical Thiazolidinedione Derivative: In Silico Design, Synthesis, and In Vivo Evaluation on a Streptozotocin-Induced Rat Model of Diabetes

Processes
2021-07 | Journal article | Author
DOI: 10.3390/pr9081294
Contributors: Samuel Álvarez-Almazán; Navarrete-Vazquez G.; Itzia Irene Padilla-Martínez; Jose Correa Basurto; Diana Alemán; Feliciano Tamay-Cach; Jessica Elena Mendieta Wejebe
Source: check_circle
Multidisciplinary Digital Publishing Institute

Current molecular aspects in the development and treatment of diabetes

Journal of Physiology and Biochemistry
2020 | Journal article
DOI: 10.1007/s13105-019-00717-0
EID:

2-s2.0-85077691028
Contributors: Álvarez-Almazán, S.; Filisola-Villaseñor, J.G.; Alemán-González-Duhart, D.; Tamay-Cach, F.; Mendieta-Wejebe, J.E.
Source: Self-asserted source
Samuel Álvarez-Almazán via Scopus - Elsevier

In silico design, chemical synthesis and toxicological evaluation of 1,3-thiazolidine-2,4-dione derivatives as PPARγ agonists

Regulatory Toxicology and Pharmacology
2017 | Journal article
DOI: 10.1016/j.yrtph.2017.02.008
EID:

2-s2.0-85013826962
Contributors: Alemán-González-Duhart, D.; Tamay-Cach, F.; Correa-Basurto, J.; Padilla-Martínez, I.I.; Álvarez-Almazán, S.; Mendieta-Wejebe, J.E.
Source: Self-asserted source
Samuel Álvarez-Almazán via Scopus - Elsevier

Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins

Biochemical Pharmacology
2017 | Journal article
DOI: 10.1016/j.bcp.2017.07.012
EID:

2-s2.0-85025446222
Contributors: Álvarez-Almazán, S.; Bello, M.; Tamay-Cach, F.; Martínez-Archundia, M.; Alemán-González-Duhart, D.; Correa-Basurto, J.; Mendieta-Wejebe, J.E.
Source: Self-asserted source
Samuel Álvarez-Almazán via Scopus - Elsevier

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones

PPAR Research
2016 | Journal article
DOI: 10.1155/2016/7614270
EID:

2-s2.0-84975069968
Contributors: Alemán-González-Duhart, D.; Tamay-Cach, F.; Álvarez-Almazán, S.; Mendieta-Wejebe, J.E.
Source: Self-asserted source
Samuel Álvarez-Almazán via Scopus - Elsevier
How many people are using ORCID?